Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 170
Selected: 0
NCT IDTitle
NCT00769652Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer
NCT03272633Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
NCT00726596Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
NCT00939380Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial
NCT00161187Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
NCT00295932Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
NCT04751747Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer
NCT06073626Addressing Genomic Disparities in Cancer Survivors
NCT00176527Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
NCT00878657Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer
NCT04253483Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer
NCT01510119Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma
NCT00996359Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation
NCT02420652Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy
NCT02400190The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
NCT00176605Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer
NCT04294264TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
NCT00323063Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer
NCT00251186First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients
NCT04146038Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease
NCT00323362Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer
NCT00118066Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia
NCT02620527Concordance Between ctDNA Assay and FoundationOne
NCT03725449Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma
NCT00323791Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
NCT04211259Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
NCT01417286Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
NCT00667901Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
NCT00176540Dextromethorphan in Treating Patients With Fatigue Caused by Cancer
NCT00899808Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer
NCT0000405812-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
NCT02748564Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
NCT02295540Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity
NCT01617161Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
NCT00905918Vitamin E Supplements in Treating Patients Undergoing Surgery for Colorectal Cancer
NCT06002282HPV Vaccine Confident Families
NCT00786682Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer
NCT03061175Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy
NCT02324621Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors
NCT00895115Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer
NCT03112668Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners
NCT05785780Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings
NCT00991315Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate
NCT05483491KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
NCT01694589A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer
NCT05400941Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary Care
NCT02699983eHealth Weight Loss Program in African American Breast Cancer Survivors
NCT02526498Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery
NCT04871516Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer
NCT02885649Enzalutamide Before Surgery in Treating Patients With Kidney Cancer